The increase in price target by JMP Securities, a reputable financial firm, suggests a strong bullish outlook on Benitec Biopharma. This is likely to instill confidence among investors, potentially driving up the stock price in the short term. The specific mention of the company and the adjustment of the price target are direct indicators of the stock's expected performance.